The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Mechanism of Action of Trazodone:a Multifunctional Drug
Abstract
Multifunctional drugs are those with more than one therapeutic mechanism. Trazodone is a multifunctional drug with dose-dependent pharmacologic actions. That is, it has hypnotic actions at low doses due to blockade of 5-HT 2A receptors, as well as H 1 histamine receptors and α1 adrenergic receptors. Higher doses recruit the blockade of the serotonin transporter (SERT) and turn trazodone into an antidepressant. Although trazodone has traditionally been used as a low dose hypnotic, a new controlled release formulation that has the potential to improve the tolerability of high doses may provide an opportunity to revisit this multifunctional drug as an antidepressant as well.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Trazodone acts by inhibiting serotonin reuptake, blocking 5‐HT2A/2C receptors, and antagonizing histamine and alpha‐1‐adrenergic receptors, contributing to its sedative effects. 30”
From Critical evaluation of real‐world evidence of repurposable medicines in the Alzheimer's disease drug development pipeline using a target trial emulation (2026) · cites this paper as [30]
Citations
Cites
Pharmacological profile of antidepressants and related compounds at human monoamine transporters
Tatsumi, M., Groshan, K., Blakely, R. D., & Richelson, E. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01393-9 · Cited by 939
Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications
Stahl, S. M. (2021) · doi:10.1017/9781108975292 · Cited by 480
Self-citationMarek, G. J., Carpenter, L. L., McDougle, C. J., & Price, L. H. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300057 · Cited by 275
Research works printed but not linked: 40
- Conn, 1987, Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic 5HT2 and 5HT1C receptors, J Pharmacol Exp Ther, 242, 552, 10.1016/S0022-3565(25)39117-2 · DOI · Paper page
- 10.1016/S0165-6147(00)01688-6 · DOI · Paper page
- Lemaire V , Benquet C , LeGarrec D , Robertson Sy , Smith D , Stahl SM , Modeling and simulation to optimize efficacy and tolerability for once a day trazodone formulation. Abstract presented at: The European College of Neuropsychopharmacology meeting; September 12-16, 2009; Istanbul, Turkey. · DOI
- 10.1017/S1092852900017089 · DOI · Paper page
- 10.1016/S0893-133X(98)00046-3 · DOI · Paper page
- 10.1016/S0893-133X(01)00333-5 · DOI · Paper page
- Stahl, 2008, Stahl's Essential Psychopharmacology
- 10.1007/BF00168661 · DOI · Paper page
- 10.1016/S0166-2236(00)02002-6 · DOI · Paper page
- 10.1523/JNEUROSCI.0112-04.2004 · DOI · Paper page
- 10.1007/BF02245118 · doi:10.1007/bf02245118
- 10.1007/s00213-008-1177-9 · DOI
- 10.1016/j.pharmthera.2006.08.004 · DOI · Paper page
- 10.1017/S1092852900000213 · DOI
- 10.1016/S0014-2999(99)00644-5 · DOI
- 10.1002/syn.20109 · DOI · Paper page
- 10.1038/sj.npp.1301287 · DOI
- 10.1093/cercor/bhh070 · DOI · Paper page
- 10.7326/0003-4819-149-10-200811180-00008 · DOI · Paper page
- 10.1007/BF02244985 · DOI · Paper page
- 10.1007/s00213-007-0710-6 · DOI
- 10.2515/therapie:2005065 · DOI · Paper page
- 10.1016/j.eurpsy.2007.01.1220 · DOI
- Nierenberg, 1992, Possible trazodone potentiation of fluoxetine: a case series, J Clin Psychiatry, 53, 83
- 10.1016/S0024-3205(00)00911-5 · DOI · Paper page
- Owens, 1997, Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites, J Pharmacol Exp Ther, 283, 1305, 10.1016/S0022-3565(24)37161-7 · DOI · Paper page
- 10.1017/S1461145707008000 · DOI
- 10.1016/j.nurt.2008.11.001 · doi:10.1016/j.nurt.2008.11.001
- 10.1097/00004714-199710000-00004 · DOI
- 10.1097/00007691-200208000-00016 · DOI
- 10.1016/j.nurt.2008.10.039 · DOI · Paper page
- 10.1097/00004714-198908000-00009 · DOI
- Shigemoto, 2004, Brain Res, 121
- Sheehan, 2009, Extended release trazodone in major depressive disorder: a randomized, double blind, placebo-controlled study, Psychiatry (Edgemont), 6, 20
- 10.1016/j.neuroscience.2006.11.004 · DOI
- Sills, 1984, Determination of selective and non-selective compounds for the 5HT1A and 5HT1B receptor subtypes in rat frontal cortex, J Pharmacol Exp Ther, 231, 480, 10.1016/S0022-3565(25)21645-7 · DOI
- 10.1016/S0731-7085(98)00117-4 · doi:10.1016/s0731-7085(98)00117-4
- Stahl, 2009, Stahls Essential Psychopharmacology Prescribers Guide
- 10.1007/s00210-004-0951-4 · DOI · Paper page
- 10.1016/j.nurt.2008.10.020 · DOI
Cited by
Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery
Atkin, T., Comai, S., & Gobbi, G. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014381 · Cited by 391
Halliday, M., Radford, H., Zents, K. A. M., Molloy, C., Moreno, J. A., Verity, N. C., Smith, E., Ortori, C. A., Barrett, D. A., Bushell, M., et al. (2017) · Brain · doi:10.1093/brain/awx074 · Cited by 293
Camargos, E. F., Louzada, L. L., Quintas, J. L., Naves, J. O. S., Louzada, F. M., & Nóbrega, O. T. (2014) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.12.174 · Cited by 170
Fluyau, D., Revadigar, N., & Manobianco, B. E. (2018) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125317753340 · Cited by 109
Martino, M., Rocchi, G., Escelsior, A., & Fornaro, M. (2012) · Current Neuropharmacology · doi:10.2174/157015912800604542 · Cited by 111
Metadata
- Authors
- Stahl, S. M.
- Venue
- CNS Spectrums
- Publisher
- Cambridge University Press (CUP)
- Published
- 2009-10
- Volume
- 14
- Issue
- 10
- Pages
- 536-546
- ISSN
- 1092-8529
- 2165-6509
- Cited by
- 266
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mechanism of Action of Trazodone:a Multifunctional Drug. https://app.cochat.ai/papers/10.1017/s1092852900024020
- The paper
- Stahl, S. M. (2009). Mechanism of Action of Trazodone:a Multifunctional Drug. CNS Spectrums. https://doi.org/10.1017/s1092852900024020
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.